This warmed-up, splashy storage project from our #DIYDARE challenge will have you smiling in the rain …read more
From:: DIY this old house
How to Make a Concrete Umbrella Stand
Ask Richard: How to Connect Pipe Without Soldering
This Old House plumbing and heating expert Richard Trethewey shows two no-solder ways to make watertight pipe connections …read more
From:: DIY this old house
Ask Richard: How to Connect Pipe Without Soldering
This Old House plumbing and heating expert Richard Trethewey shows two no-solder ways to make watertight pipe connections …read more
From:: DIY this old house
1830s Farmhouse Remodel Fit for a Family
The old farmhouse had dark rooms, dead ends, and no place to park the kids’ boots. Here’s how an inventive redo made an 1830s artifact just right for a 21st-century household …read more
From:: DIY this old house
NYC homes: Costs behind the film industry’s desired location
As New York City becomes more common than ever to film in, so does the opportunity for New Yorkers to turn their homes into film studios. While the gig comes with a pretty pay out, it also comes at another price. …read more
From:: Real Estate Wire
RPM Mortgage ranked above average by S&P for third straight year
Private mortgage lender RPM Mortgage announced that for the third straight year, Standard & Poor’s placed its US residential mortgage originator ranking at “Above Average” after it reviewed the company’s origination process for prime residential mortgages. And, here are the 4 reasons why the ratings agency is so impressed. …read more
From:: Real Estate Wire
Avon Products to cut 2,500 positions worldwide
Avon Products Inc. said Monday it will cut about 2,500 positions worldwide as part of its reorganization plan announced in January. The workforce reduction includes both filled and open positions, the beauty products company said. Avon said it expects charges of about $60 million before taxes in the first quarter of 2016 as a result, mostly to cover employee-related costs. The company expects pre-tax savings of about $30 million in 2016, and expects annualized pre-tax savings between $65 million to $70 million beginning next year, it said. Avon, which recently sold its North American business and now has commercial operations fully outside the U.S., said it will continue to operate facilities in New York state and continue to be incorporated in the U.S. “The North American business is not impacted by any of today’s actions,” the company said in a statement. Shares of Avon rose 3.9% in late trading Monday after ending the regular session up 4.3%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News
Celator Pharma shares skyrocket more than 300% on study data
Celator Pharmaceuticals Inc. shares skyrocketed in the extended session Monday after the tiny biotech said its drug candidate significantly improved survival in blood cancer patients. Celator shares jumped 357% to $7.68 on volume of more than 6.4 million shares after hours. Average daily trading volume for Celator shares has been just under 376,000 shares over the past 52 weeks. In a late-stage clinical trial, the company said acute myeloid leukemia patients taking its treatment, Vyxeos, survived an average of 9.6 months, compared with 6 months in patients using standard-of-care treatments.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News
Celator Pharma shares skyrocket more than 300% on study data
Celator Pharmaceuticals Inc. shares skyrocketed in the extended session Monday after the tiny biotech said its drug candidate significantly improved survival in blood cancer patients. Celator shares jumped 357% to $7.68 on volume of more than 6.4 million shares after hours. Average daily trading volume for Celator shares has been just under 376,000 shares over the past 52 weeks. In a late-stage clinical trial, the company said acute myeloid leukemia patients taking its treatment, Vyxeos, survived an average of 9.6 months, compared with 6 months in patients using standard-of-care treatments.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News
Morgan Stanley: Global recession risk rises 30% this year
By jgaffney@housingwire.com Morgan Stanley is hinting that we should all consider cancelling our summer vacations. Quants at the Wall Street investment bank say the risk of the global economy sliding back into a recession is now nearly a one-in-three shot, according to coverage in the Telegraph UK. But why? …read more
From:: Real Estate Wire